1-3 of 3
Laurie Catley
Close
Sort by
Journal Articles

Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL + leukemias

Ellen Weisberg, Laurie Catley, Renee D. Wright, Daisy Moreno, Lolita Banerji, Arghya Ray, Paul W. Manley, Juergen Mestan, Doriano Fabbro, Jingrui Jiang, Elizabeth Hall-Meyers, Linda Callahan, Jamie L. DellaGatta, Andrew L. Kung, James D. Griffin
Journal: Blood
Blood (2006) 109 (5): 2112–2120.
https://doi.org/10.1182/blood-2006-06-026377
Published: 2006
Includes: Supplemental data
Journal Articles

Constitutive Expression of CD40L on Bone Marrow Mast Cells Supports the Growth of Lymphoplasmacytic Cells in Patients with Waldenstrom’s Macroglobulinemia.

Olivier Tournilhac, Daniel Ditzel Santos, Lian Xu, Jeffery Kutok, Yu Tsu Tai, Steven Le Gouill, Evdoxia Hatjiharissi, Laurie Catley, Zachary Hunter, Andrew Branagan, Kenneth C. Anderson, Steven P. Treon
Journal: Blood
Blood (2004) 104 (11): 2350.
https://doi.org/10.1182/blood.V104.11.2350.2350
Published: 2004
Journal Articles

Lymphoplasmacytic Cells and Mast Cells Are Targets for Imatinib Mesylate (Gleevec, Glivec) in Waldenstrom’s Macroglobulinemia.

Olivier Tournilhac, Daniel Ditzel Santos, Lian Xu, Evdoxia Hatjiharissi, Yu Tsu, Tai, Laurie Catley, Zachary Hunter, Andrew Branagan, Renate Burger, Reshma Shringarpure, Joshua Boyce, Kenneth C. Anderson, Steven P. Treon
Journal: Blood
Blood (2004) 104 (11): 4929.
https://doi.org/10.1182/blood.V104.11.4929.4929
Published: 2004